LTBP4 and Duchenne muscular dystrophy: Long-term 24-week administration of anti-LTBP4 antibody improved muscle performance and reduced muscle fibrosis, including in the diaphragm muscle, one of the most adversely affected muscles in DMD and its mouse models.